关于JSR Life Sciences

了解我们

JSR Life Sciences brings together the deep biochemical knowledge and understanding of human disease, expertise in drug discovery and development, and access to capital into a single, integrated framework that creates value for our customers.

JSR supports the drug discovery and development needs of our partners with tailored solutions that identifies and applies the right tools and technologies to support their unique therapeutic programs. From de-risking molecule selection and accelerating biologic development timelines, to increasing clinical success rates and developing in vitro diagnostics, JSR Life Sciences is committed to guiding our customers’ innovative science along the path to becoming life-saving medicines.

Accelerating Our Life Sciences Footprint

We offer our partners best-in-class research products and services for outsourced drug discovery and development. With our proprietary products and services and through our affiliate companies, JSR has a global presence including 28 sites in seven countries.

Our Affiliates

We leverage the core competencies of our affiliates to create integrated solutions that are designed to guide our partners’ programs from the lab through commercialization.

Crown Bioscience
Contract research organization with advanced technology for precision medicine

Similis Bio
Similis Bio jump-starts your biosimilar program with pre-qualified analytical methods, detailed reference product characterization & off-the-shelf assets.

MBL
Biomarker discovery for companion and in vitro diagnostics

KBI Biopharma
Global contract development and manufacturing organization with advanced analytical capabilities


JSR’s specialty life science research products include:

Amsphere A3, a protein A chromatography resin for advanced protein separation

Magnosphere hydrophilic and hydrophobic microparticles for research and in vitro diagnostics use

JSR Life Sciences is a business unit of JSR Corporation, a multinational advanced materials and solutions company based in Japan.

JSR Life Sciences最新新闻

冠科生物任命顾延为首席执行官

中美冠科生物科技公司任命 John Gu 为首席执行官,利用他在人工智能驱动的药物研发方面的专业知识来推动生物技术创新和全球健康。

冠科生物完成与Indivumed Services战略整合

Crown Bioscience 完成 Indivumed Services 合并,在全球范围内提供增强的药物开发解决方案,并停用 Indivumed 品牌。

冠科生物德国公司再次荣获CAP ISO 15189:2022认证

冠科生物德国公司再次荣获CAP ISO 15189:2022认证

Receive JSR Life Sciences news on your RSS reader.

Or subscribe through Atom URL manually